题目内容
(请给出正确答案)
[单选题]
CameL研究显示ITT人群中卡瑞利珠单抗联合化疗组的DCR是()
A.87.3%
B.84.6%
C.74.4%
D.70.4%
答案
A、87.3%
如果结果不匹配,请 联系老师 获取答案
A.87.3%
B.84.6%
C.74.4%
D.70.4%
A、87.3%
A.2 (4.8%)
B.23 (54.8%)
C.12 (28.6%)
D.4 (9.5%)
A.59.5%,7.6个月,未达到
B.59.5%,7.6个月,12.1个月
C.59.5%,8.6个月,12.1个月
D.59.5%,7.6个月,13.1个月
A.171ML
B.175ML
C.179ML
D.184ML
A.患者接受卡瑞利珠单抗+卡铂+培美曲塞治疗
B.卡瑞利珠单抗的用量为250mg
C.每21天为周期用药一次
D.患者需进行6-8个周期的治疗
A.22%
B.43.2%
C.77.3%
D.9.5%
A.1%
B.2.4%
C.4.8%
D.9%
A.卡瑞利珠单抗200mgQ2W+阿帕替尼500mgQD
B.卡瑞利珠单抗200mgQ3W+阿帕替尼250mgQD
C.卡瑞利珠单抗200mgQ3W+阿帕替尼500mgQD
D.卡瑞利珠单抗200mgQ2W+阿帕替尼250mgQD